Liminatus Pharma LIMN
NASDAQ LIMN
$3.91 -0.36 (-8.43%)
At close: Sep 29, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Non-Current Assets (2024 - 2026)

Updated

Liminatus Pharma's Non-Current Assets was $11,235 in Q2 2026, down 91.1% from $126,473 a year earlier and down 4.0% from the prior quarter.

Analysis

Liminatus Pharma (LIMN) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Assets at Liminatus Pharma came in at $12,221, down 90.4% from FY2024.

  • In earlier years, Non-Current Assets was $127,216 in FY2024.
  • Per Business Quant data, LIMN's Non-Current Assets in the three quarters before Q2 2026 was $11,703 (Q1 2026), $12,221 (Q4 2025) and $139,039 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Liminatus Pharma 4.78 Mn 4.78 Mn - 11,235.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,235.00
Mar 31, 2026 11,703.00
Dec 31, 2025 12,221.00
Sep 30, 2025 139,039.00
Jun 30, 2025 126,473.00
Dec 31, 2024 127,216.00
API Access

Liminatus Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=LIMN&period=max&api_key=YOUR_API_KEY